Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-13

Clinical Trial Update: Quinidine Versus Verapamil in Short-coupled Idiopathic Ventricular Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing quinidine and verapamil for short-coupled idiopathic ventricular fibrillation is in an unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quinidine (quinidine)
  • Verapamil (verapamil)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Short-coupled Idiopathic Ventricular Fibrillation | Phase 2 | Status: UNKNOWN